Equity

Growth Equity

Minority growth capital for proven, scaling companies — without ceding control.

Growth EquityImage · Growth Equity
Overview

Growth equity is a minority investment into a company with proven product-market fit and revenue, funding expansion rather than survival, with founders typically retaining control. Matchpoint raises growth equity from PE and crossover investors.

As part of our Equity practice, Matchpoint Partners has originated and led $2+ billion of transactions across four continents, and every equity mandate is led by a partner, from first call to close.

The central mandate decision. Set the amount, valuation range and dilution tolerance against the milestones the new capital must fund. The process should show why a minority investment can create a larger and more valuable business without creating an avoidable control dispute.

Growth capital is sized around the milestones between proven traction and institutional scale.
Growth capital is sized around the milestones between proven traction and institutional scale.

What capital providers or counterparties will test

Revenue quality, gross margin, customer concentration, unit economics, cash conversion, management depth, governance, the route to profitability and the credibility of the expansion plan.

How the mandate is structured

Primary equity is usually combined with governance rights, information rights and reserved matters. A secondary component may provide measured shareholder liquidity where it does not weaken the company balance sheet or investor alignment.

Execution priorities

Build the operating case and downside case first; then calibrate valuation, investor type, primary versus secondary proceeds and the milestones required before the next financing or exit.

Prepare before approaching the market

  • Three-year integrated financial model with downside sensitivities
  • Cohort, customer and margin analysis
  • Cap table and proposed primary/secondary split
  • Expansion plan with use of funds and milestone dates
How Matchpoint helps

Our role on growth equity mandates

  • Minority, non-control investments
  • Capital to scale teams, markets and capacity
  • Founders retain control
  • PE and crossover investor relationships
Growth Equity mandates from USD 5mState the transaction, amount, jurisdiction and use of funds.
Decision authorityOwner, board, sponsor or authorised adviser.
Written engagementRetainer and success fee agreed before work begins.
Discuss a mandate
Track record

Select transactions

Representative equity mandates led by Matchpoint partners.

Healthcare · India
$50m

Series-D raise for a tertiary healthcare hospital group.

Capital Raise Adviser · Asia
Battery Tech · UAE
$10m

Growth financing for a battery-technology venture.

Capital Raise Adviser · UAE
Technology · UAE
$10m

Growth financing for a UAE technology venture.

Capital Raise Adviser · UAE
Retail · UAE
$10m

Growth financing for a UAE retail business.

Capital Raise Adviser · UAE
Questions, answered

Growth Equity — frequently asked questions

It backs established, growing businesses with less technology/market risk than venture, usually as a minority stake.

Often USD 10m–150m, depending on the company and round.

A company is ready for growth equity when it has proven product-market fit, recurring or repeatable revenue, sound unit economics and a clear plan for deploying capital into expansion. Investors also expect reliable financial reporting and a management team with the depth to execute the growth plan.

Growth equity investors look for an established business with demonstrated demand, a scalable model and a defined use of proceeds — new markets, capacity or team build-out. Because they take minority positions, they also weigh governance rights, alignment with founders and a realistic route to exit within their fund life.

Growth equity terms usually include a minority shareholding with board representation, information rights, liquidation preference and consent rights over major decisions, while founders retain operational control. Negotiating these protections carefully — alongside valuation — determines how much freedom management keeps and how aligned both sides are at exit.

Matchpoint prepares your equity story and investor materials, maps your raise against a curated base of PE funds, family offices, SWFs, VCs and strategic investors, and runs the process to close. Typical equity tickets range from USD 5m to USD 300m.

Assess the adviser against the transaction size, sector and geography; the quality of its investor-screening method; senior involvement; preparation capability; conflicts; process reporting; fee transparency; and its ability to support diligence and term-sheet comparison. Ask to see the proposed deliverables and qualification fields before any outreach begins.

The target list should record each investor's sector, stage, geography, cheque size, preferred instrument, governance requirements, relevant portfolio or transaction evidence, conflicts, relationship route and the reason the investor fits the mandate. It should be prioritised and updated as feedback is received.

Venture capital funds early-stage, high-growth companies (seed to Series C) for minority equity, while private equity backs more established businesses via growth equity, buy-outs or minority stakes. We raise both, matching the investor to your stage and sector.

Yes. We support founders from MVP traction through growth rounds — building the pitch, model and go-to-market narrative, then introducing the company to seed and growth-stage investors across MENA and India.

Engagements ordinarily combine a retainer with a success fee. Terms are agreed in writing before work begins and calibrated to the mandate’s size, scope and complexity.

Most mandates reach a first term sheet within 30 days, depending on diligence readiness and structure; closing follows once terms are agreed.

A short, confidential scoping call and NDA; we structure the requirement and prepare materials, then run a competitive process across our 5,000+ investor and lender relationships, and negotiate to close — with a partner leading at every step.

Matchpoint Partners is based in the UAE and runs cross-border mandates across the UAE, KSA, India and the UK, with active deal activity in wider Europe, Singapore and the United States.

Matchpoint undertakes corporate finance, financing, M&A and fund-placement mandates from USD 5m upwards, subject to mandate fit, diligence, applicable regulation, capacity and a written engagement. The partner team has originated and led $2+ billion of transactions.

Use the enquiry form, email contact@matchpoint-partners.com, or call/WhatsApp +971 52 345 1119. Every mandate is led by a partner from the very first conversation.

Yes. Confidential information is handled under the engagement terms and any applicable non-disclosure agreement.

Interested in growth equity?

Tell us your requirement and a partner will respond personally.

Growth-capital decision

How do I raise equity capital in the UAE?

Define the amount, use of proceeds, milestones and ownership outcome before approaching investors. A credible process needs a defensible financial model, valuation logic, cap table, governance proposal, evidence for the growth case and a diligence-ready data room. Investor selection should follow sector, stage, cheque size, geography, return profile and strategic fit.

01

Who this route fits

Proven companies and founders seeking institutional growth equity, strategic investment or family-office capital.

02

Decisions before outreach

Amount; valuation; dilution; investor rights; board composition; liquidation terms; use of proceeds; and future funding needs.

03

What to prepare

Investment deck, operating model, historical financials, cap table, valuation support, commercial evidence, governance and data room.

Qualification. Matchpoint undertakes equity mandates from USD 5m upwards, subject to stage, evidence, valuation and mandate fit.

Capital markets ecosystem

Investment roles, structures and decision criteria

Explore the participants and transaction options relevant to this practice. Each entry sets out a discussion scope, decision checks, a paid engagement starting point and the specialist responsibilities to confirm.

Private Capital

Growth EquityCME-147 · Private Capital · Asset Class
Ecosystem role
Asset Class
Related asset class
Private markets
Instrument context
Equity or debt

Mandate context: equity, credit and private-company investment strategies. The structure and rights are established by the specific transaction documents.

Decision focus: Economic exposure and downside assumptions.

  • Underlying business or borrower evidence
  • Cash-flow rights, leverage and valuation
  • Liquidity, governance and exit or repayment routes

Scope to discuss: Private-markets portfolio strategy, manager selection, diligence and transaction access.

Paid engagement entry point: allocation and market-opportunity study; followed by manager or asset screening and diligence.

Illustrative GCC scenario: An illustrative GCC private-capital comparison can evaluate equity and credit exposures on a consistent set of cash-flow, governance and liquidity assumptions. This is a hypothetical decision example.

What should be agreed before a mandate involving Growth Equity?

Define the investment or transaction objective, the authorised decision-maker, the evidence available, the requested deliverables and the next approval. Use the decision checks above to identify gaps; agree the workplan, delivery responsibilities and fee terms in writing.

Delivery and specialist boundary: Confirm decision authority, evidence access, conflicts, scope and applicable jurisdiction-specific permissions before execution. Legal, tax, fund-marketing, securities and Shariah questions require the relevant appointed specialist. Capital availability, investment returns and execution dates remain subject to assessment.

Discuss a paid scope

Further reading on diligence, market frameworks and applicable requirements. These resources do not verify an individual mandate or Matchpoint permission.

Matchpoint decision framework

Growth capital for expansion, strategic partnerships and acquisitions

Editorial update: 2026-09-07

Growth equity has to fund an identifiable business plan. A useful financing brief distinguishes investment in the operating company from a secondary purchase of existing shares. It also explains what the company can accomplish with a smaller raise, a staged commitment or a different investor mix. These are decision alternatives to evaluate, not promised funding routes.

Regional expansion

Build a country-by-country operating case: customer evidence, route to market, management coverage, working-capital needs and launch dependencies. Identify spending that can be deferred and obligations that cannot. Present local approvals as an item for qualified jurisdiction-specific review. Investors should be able to distinguish demonstrated demand from management estimates and proposed market entry.

Strategic investor participation

Document the proposed commercial relationship separately from the equity investment. Examine exclusivity, distribution rights, intellectual property, information access, customer concentration and restrictions on future investors. Model the company without the proposed partnership benefits as well as with them. State which benefits are contractually documented, under discussion or only illustrative.

Acquisition-led growth

Reconcile the purchase price, fees, refinancing, integration spending and minimum operating liquidity. Identify how equity commitments interact with debt conditions and acquisition signing or closing. Keep base-case value creation separate from unproven synergies. A funded acquisition still needs an accountable integration plan, an operating baseline and a process for monitoring delivery.

Decision preparation checklist

  1. Primary versus secondary proceeds
  2. Evidence-backed expansion assumptions
  3. Commercial and equity rights kept visible
  4. Acquisition sources and uses
  5. Post-investment reporting and owner accountability

Practical questions

What should a growth-capital brief include?

Include the operating objective, funding amount, ownership limits, historical evidence, scenarios, proposed investor profile and key execution dependencies.

Should strategic benefits be included in every valuation case?

Show them separately with their assumptions and evidence. A case excluding uncertain benefits helps the decision-maker understand dependence on the proposed partnership.

Related decision paths

Discuss your decision with Matchpoint

Start with a non-confidential brief covering the objective, jurisdictions, current stage, timing and open decisions. Any engagement is subject to fit, jurisdictional review, written scope and agreed fees. Please do not submit confidential third-party information through a public form.

Request a mandate discussion

Founder credentials: Chennakeshav (CK) Adya

This paper is part of a continuing series on the structure of private and alternative markets. The views expressed are the author's own. The paper is for information only, describes market structure in general terms, and does not constitute investment, legal, tax or regulatory advice or a recommendation in respect of any security, vehicle or counterparty.

WhatsApp